Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) have received an average rating of “Moderate Buy” from the ten analysts that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating and eight have issued a buy rating on the company. The average […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.